ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 655,41
-0,09%
Dow Jones
39 112,16
-0,76%
DAX
18 267,69
0,58%
Brent Oil
84,965
0,93%
Bitcoin
61 317,28
-0,80%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Gpc Biotech AG ADS (MM) (GPCB)

  7. Gpc Biotech AG ADS (MM) (GPCB) Actualités

GPCB

Gpc Biotech AG ADS (MM) (GPCB)

Gpc Biotech AG ADS (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GPCB
DateHeureSourceTitreSymboleSociété
21/04/200916h12Business WireNew Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor Presented at AACRNASDAQ:GPCBGpc Biotech AG ADS (MM)
25/03/200907h40Business WireGPC Biotech Reports Financial Results for Fiscal Year 2008NASDAQ:GPCBGpc Biotech AG ADS (MM)
23/02/200920h17Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
18/02/200902h31Business WireGPC Biotech and Agennix Announce Proposed MergerNASDAQ:GPCBGpc Biotech AG ADS (MM)
09/12/200810h10Business WireGPC Biotech Opens Enrollment in Phase 1 Trial Evaluating RGB-286638 Multi-Targeted Protein Kinase Inhibitor in Patients with ...NASDAQ:GPCBGpc Biotech AG ADS (MM)
13/11/200807h40Business WireGPC Biotech Reports Financial Results For Third Quarter and First Nine Months of 2008NASDAQ:GPCBGpc Biotech AG ADS (MM)
06/11/200815h42Business WireGPC Biotech to Present at Rodman & Renshaw Annual Global Investment Conference in New YorkNASDAQ:GPCBGpc Biotech AG ADS (MM)
25/08/200821h13Edgar (US Regulatory)Gpc Biotech Ag - Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
07/08/200800h01Business WireGPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for SatraplatinNASDAQ:GPCBGpc Biotech AG ADS (MM)
25/07/200822h15Business WireGPC Biotech Reports That Marketing Authorization Application for Satraplatin is to Be WithdrawnNASDAQ:GPCBGpc Biotech AG ADS (MM)
12/06/200810h05Business WireGPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refractory to TaxanesNASDAQ:GPCBGpc Biotech AG ADS (MM)
05/06/200808h49Business WireGPC Biotech to Present at Two Upcoming Conferences: 7th Annual Needham Biotechnology & Medical Technology Conference in New YorkNASDAQ:GPCBGpc Biotech AG ADS (MM)
02/06/200809h06Business WireData from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial ChemotheNASDAQ:GPCBGpc Biotech AG ADS (MM)
02/06/200809h05Business WireNew Data from Several Satraplatin Clinical Trials in Solid Tumors Presented at 44th ASCO Annual MeetingNASDAQ:GPCBGpc Biotech AG ADS (MM)
28/05/200809h07Business WireGPC Biotech Announces Data from Several Satraplatin Clinical Trials to be Presented at ASCO Annual MeetingNASDAQ:GPCBGpc Biotech AG ADS (MM)
15/05/200808h36Business WireGPC Biotech Reports Financial Results for First Quarter 2008NASDAQ:GPCBGpc Biotech AG ADS (MM)
31/01/200819h42Edgar (US Regulatory)Gpc Biotech Ag - Amended Statement of Ownership (SC 13G/A)NASDAQ:GPCBGpc Biotech AG ADS (MM)
31/10/200704h35PR Newswire (US)GPC Biotech Today Announced Results of Survival Analysis from the SPARC TrialNASDAQ:GPCB
31/10/200704h27PR Newswire (US)Pharmion and GPC Biotech Announce Results of Overall Survival Analysis From the Satraplatin Pivotal Phase 3 TrialNASDAQ:GPCB
28/09/200717h12Edgar (US Regulatory)Gpc Biotech Ag (Other) (SC 13G)NASDAQ:GPCBGpc Biotech AG ADS (MM)
24/08/200700h00PR Newswire (US)Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLPNASDAQ:GPCBGpc Biotech AG ADS (MM)
23/08/200707h58PR Newswire (US)GPC Biotech Announces RestructuringNASDAQ:GPCB
21/08/200716h41PR Newswire (US)Finkelstein Thompson LLP Announces GPC Biotech AG InvestigationNASDAQ:GPCBGpc Biotech AG ADS (MM)
08/08/200708h37PR Newswire (US)GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2007NASDAQ:GPCB
02/08/200712h05PR Newswire (US)GPC Biotech Schedules Conference Call on August 8th to Discuss First Half 2007 Financial ResultsNASDAQ:GPCB
30/07/200715h57PR Newswire (US)GPC Biotech Withdraws Satraplatin NDA Filed for Accelerated ApprovalNASDAQ:GPCB
30/07/200715h48PR Newswire (US)GPC Biotech Withdraws Satraplatin NDA For Accelerated Approval; Plans to Resubmit With Survival AnalysisNASDAQ:GPCB
28/07/200704h30PR Newswire (US)Law Offices of Howard G. Smith Announces Class Action Lawsuit Against GPC BiotechNASDAQ:GPCBGpc Biotech AG ADS (MM)
27/07/200720h05PR Newswire (US)GPC Biotech AG Named in Purported Class Action Lawsuit in the United StatesNASDAQ:GPCB
27/07/200713h00PR Newswire (US)Marketing Authorization Application for Satraplatin Accepted for Review by the European Medicines AgencyNASDAQ:GPCB
 Showing the most relevant articles for your search:NASDAQ:GPCB

Dernières Valeurs Consultées

LSE
AH82
Corp Andina 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés